Joseph J.  Stich net worth and biography

Joseph Stich Biography and Net Worth

SVP of Surmodics
Joseph J. Stich is Senior Vice President and General Manager of Human Resources and In Vitro Diagnostics. Joe joined Surmodics in March 2010 as Vice President of Corporate Development and Strategy and added the responsibilities of Marketing in October 2010. He was named Vice President of Business Operations and General Manager of In Vitro Diagnostics in August 2011 and Vice President and General Manager of In Vitro Diagnostics in September 2013. In April 2020, he was promoted to his current role and assumed responsibility for Human Resources. Prior to Surmodics, Joe was Vice President of Corporate Development for Abraxis Bioscience, LLC, from 2009 to 2010 and was a Vice President for Eisai Pharmaceuticals (MGI PHARMA, Inc.) from 2005 to 2009. Prior experience also includes serving as President and Chief Operating Officer of Pharmaceutical Corp. of America (a subsidiary of Publicis Healthcare Specialty Group) and positions of increasing responsibility in sales and marketing at Sanofi-Aventis Pharmaceuticals. Joe received a BBA from the University of Wisconsin – Whitewater in 1988, and an MBA from Rockhurst University in Kansas City in 1996.

What is Joseph J. Stich's net worth?

The estimated net worth of Joseph J. Stich is at least $1.98 million as of January 5th, 2021. Mr. Stich owns 50,562 shares of Surmodics stock worth more than $1,980,514 as of November 21st. This net worth estimate does not reflect any other investments that Mr. Stich may own. Additionally, Mr. Stich receives an annual salary of $570,920.00 as SVP at Surmodics. Learn More about Joseph J. Stich's net worth.

How old is Joseph J. Stich?

Mr. Stich is currently 59 years old. There are 6 older executives and no younger executives at Surmodics. The oldest executive at Surmodics is Mr. Gary R. Maharaj, CEO, President & Director, who is 61 years old. Learn More on Joseph J. Stich's age.

What is Joseph J. Stich's salary?

As the SVP of Surmodics, Inc., Mr. Stich earns $570,920.00 per year. There are 5 executives that earn more than Mr. Stich. The highest earning executive at Surmodics is Mr. Gary R. Maharaj, CEO, President & Director, who commands a salary of $1,330,000.00 per year. Learn More on Joseph J. Stich's salary.

How do I contact Joseph J. Stich?

The corporate mailing address for Mr. Stich and other Surmodics executives is 9924 WEST 74TH STREET, EDEN PRAIRIE MN, 55344. Surmodics can also be reached via phone at (952) 500-7000 and via email at [email protected]. Learn More on Joseph J. Stich's contact information.

Has Joseph J. Stich been buying or selling shares of Surmodics?

Joseph J. Stich has not been actively trading shares of Surmodics in the last ninety days. Most recently, Joseph J. Stich sold 2,500 shares of the business's stock in a transaction on Tuesday, January 4th. The shares were sold at an average price of $50.00, for a transaction totalling $125,000.00. Learn More on Joseph J. Stich's trading history.

Who are Surmodics' active insiders?

Surmodics' insider roster includes Jose Bedoya (Director), David Dantzker (Director), Gary Maharaj (CEO), John Manders (Insider), Charles Olson (VP), and Joseph Stich (SVP). Learn More on Surmodics' active insiders.

Joseph J. Stich Insider Trading History at Surmodics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/4/2022Sell2,500$50.00$125,000.00View SEC Filing Icon  
8/19/2021Sell2,500$54.40$136,000.00View SEC Filing Icon  
5/20/2021Sell2,500$53.80$134,500.00View SEC Filing Icon  
1/5/2021Sell2,500$45.00$112,500.0050,562View SEC Filing Icon  
6/9/2020Sell2,500$45.00$112,500.00View SEC Filing Icon  
9/23/2019Sell2,000$46.32$92,640.00View SEC Filing Icon  
8/1/2019Sell2,000$47.00$94,000.0050,637View SEC Filing Icon  
3/29/2019Sell1,900$45.00$85,500.0052,637View SEC Filing Icon  
3/22/2019Sell100$45.54$4,554.00View SEC Filing Icon  
2/15/2019Sell2,000$55.25$110,500.0055,894View SEC Filing Icon  
11/9/2018Sell2,000$63.77$127,540.00View SEC Filing Icon  
8/10/2018Sell2,000$69.76$139,520.0053,819View SEC Filing Icon  
6/5/2018Sell2,000$52.44$104,880.00View SEC Filing Icon  
3/9/2018Sell1,000$33.53$33,530.00View SEC Filing Icon  
12/11/2017Sell1,000$30.18$30,180.0046,450View SEC Filing Icon  
9/11/2017Sell1,000$27.28$27,280.00View SEC Filing Icon  
6/9/2017Sell1,000$25.31$25,310.0040,672View SEC Filing Icon  
3/6/2017Sell1,000$24.73$24,730.00View SEC Filing Icon  
12/5/2016Sell1,000$23.97$23,970.0042,362View SEC Filing Icon  
6/10/2016Sell1,000$23.33$23,330.0023,492View SEC Filing Icon  
12/4/2015Sell1,000$21.18$21,180.0021,464View SEC Filing Icon  
9/4/2015Sell1,000$23.57$23,570.0022,464View SEC Filing Icon  
6/5/2015Sell1,000$23.84$23,840.00View SEC Filing Icon  
See Full Table

Joseph J. Stich Buying and Selling Activity at Surmodics

This chart shows Joseph J Stich's buying and selling at Surmodics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Surmodics Company Overview

Surmodics logo
Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for neurovascular, peripheral, coronary, and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.
Read More

Today's Range

Now: $39.17
Low: $39.10
High: $39.24

50 Day Range

MA: $38.49
Low: $37.50
High: $39.44

2 Week Range

Now: $39.17
Low: $25.17
High: $42.44

Volume

20,906 shs

Average Volume

229,636 shs

Market Capitalization

$558.96 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2